BRWA
EBS icon

B. Riley Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History

B. Riley Wealth Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,500
Closed -$130K – 953
2025
Q4 		$130K Sell
10,500
-20,300
-66% -$218K 0.01% 914
2025
Q3 		$272K Sell
30,800
-7,000
-19% -$54.4K 0.01% 761
2025
Q2 		$241K Sell
37,800
-4,000
-10% -$22.9K 0.01% 799
2025
Q1 		$203K Hold
41,800
– – 0.01% 1143
2024
Q4 		$400K Buy
41,800
+7,500
+22% +$68.8K 0.01% 770
2024
Q3 		$295K Buy
+34,300
New +$312K 0.01% 960
2016
Q1 		– Sell
-7,102
Closed -$285K – 564
2015
Q4 		$285K Buy
+7,102
New +$248K 0.06% 381

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

B. Riley Wealth Advisors's EBS Position: Q1 2026 in Review

B. Riley Wealth Advisors sold out of Emergent Biosolutions (EBS) in Q1 2026, closing a stake of 10,500 shares — an estimated $130K sold.

B. Riley Wealth Advisors first reported a position in EBS in Q4 2015 and held it in 7 quarters. The position peaked at $400K in Q4 2024. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • B. Riley Wealth Advisors reported no remaining Emergent Biosolutions position as of Q1 2026 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 10,500 Emergent Biosolutions shares in Q1 2026, an estimated $130K.
  • B. Riley Wealth Advisors first reported a position in Emergent Biosolutions in Q4 2015 and held it in 7 quarters.
  • B. Riley Wealth Advisors's Emergent Biosolutions position peaked at $400K in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.